Rowinsky EK - Search Results

1

Camptothecin analogues: studies from the Johns Hopkins Oncology Center.

Slichenmyer WJ, Rowinsky EK, Grochow LB, Kaufmann SH, Donehower RC. Slichenmyer WJ, et al. Among authors: rowinsky ek. Cancer Chemother Pharmacol. 1994;34 Suppl:S53-7. doi: 10.1007/BF00684864. Cancer Chemother Pharmacol. 1994. PMID: 7520844 Clinical Trial.

2

Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function.

O'Reilly S, Rowinsky E, Slichenmyer W, Donehower RC, Forastiere A, Ettinger D, Chen TL, Sartorius S, Bowling K, Smith J, Brubaker A, Lubejko B, Ignacio V, Grochow LB. O'Reilly S, et al. J Natl Cancer Inst. 1996 Jun 19;88(12):817-24. doi: 10.1093/jnci/88.12.817. J Natl Cancer Inst. 1996. PMID: 8637048 Clinical Trial.

3

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

Rowinsky EK, Grochow LB, Hendricks CB, Ettinger DS, Forastiere AA, Hurowitz LA, McGuire WP, Sartorius SE, Lubejko BG, Kaufmann SH, et al. Rowinsky EK, et al. J Clin Oncol. 1992 Apr;10(4):647-56. doi: 10.1200/JCO.1992.10.4.647. J Clin Oncol. 1992. PMID: 1312588 Clinical Trial.

4

Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue.

Hendricks CB, Rowinsky EK, Grochow LB, Donehower RC, Kaufmann SH. Hendricks CB, et al. Among authors: rowinsky ek. Cancer Res. 1992 Apr 15;52(8):2268-78. Cancer Res. 1992. PMID: 1348448

5

Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer.

Grochow LB, Rowinsky EK, Johnson R, Ludeman S, Kaufmann SH, McCabe FL, Smith BR, Hurowitz L, DeLisa A, Donehower RC, et al. Grochow LB, et al. Among authors: rowinsky ek. Drug Metab Dispos. 1992 Sep-Oct;20(5):706-13. Drug Metab Dispos. 1992. PMID: 1358575

6

The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics.

Rowinsky EK, Donehower RC. Rowinsky EK, et al. Pharmacol Ther. 1991 Oct;52(1):35-84. doi: 10.1016/0163-7258(91)90086-2. Pharmacol Ther. 1991. PMID: 1687171 Review.

7

Phase I and pharmacokinetic study of hepsulfam (NSC 329680).

Hendricks CB, Grochow LB, Rowinsky EK, Forastiere AA, McGuire WP, Ettinger DS, Sartorius S, Lubejko B, Donehower RC. Hendricks CB, et al. Among authors: rowinsky ek. Cancer Res. 1991 Nov 1;51(21):5781-5. Cancer Res. 1991. PMID: 1933848 Clinical Trial.

8

Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.

Hantel A, Donehower RC, Rowinsky EK, Vance E, Clarke BV, McGuire WP, Ettinger DS, Noe DA, Grochow LB. Hantel A, et al. Among authors: rowinsky ek. Cancer Res. 1990 Jun 1;50(11):3284-8. Cancer Res. 1990. PMID: 2334921

9

Phase I and pharmacokinetic study of brequinar sodium (NSC 368390).

Noe DA, Rowinsky EK, Shen HS, Clarke BV, Grochow LB, McGuire WB, Hantel A, Adams DB, Abeloff MD, Ettinger DS, et al. Noe DA, et al. Among authors: rowinsky ek. Cancer Res. 1990 Aug 1;50(15):4595-9. Cancer Res. 1990. PMID: 2369734

10

Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

Rowinsky EK, Burke PJ, Karp JE, Tucker RW, Ettinger DS, Donehower RC. Rowinsky EK, et al. Cancer Res. 1989 Aug 15;49(16):4640-7. Cancer Res. 1989. PMID: 2568175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters